Our Pricing

Mounjaro Discount Code - Save £10 on First Order

Published on: June 03, 2026

Searching for a genuine mounjaro discount code uk pharmacy offer? At Cured Pharmacy, you'll Save £10 on your first Mounjaro order with transparent upfront pricing from £124.99, free clinical consultation with UK prescribers, and 100% discreet delivery. Unlike other online pharmacies that hide costs until checkout, we show you exactly what you'll pay before your consultation begins.

How the Mounjaro Discount Code UK Works at Cured Pharmacy

Our mounjaro discount code uk pharmacy pricing is automatically applied when you complete your free online consultation — no voucher codes to remember or promotional hoops to jump through. You'll see the discounted price of £135.00 displayed upfront for the 2.5mg starting dose, which represents substantial savings compared to typical market rates across UK online pharmacies.

Every Mounjaro prescription at Cured Pharmacy includes a comprehensive clinical assessment by our UK-registered prescribers, all MHRA-licensed medication dispensed from our GPhC-registered pharmacy (9012511), and free discreet delivery to your door. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees every prescription to ensure you receive genuine UK-licensed tirzepatide pens, not grey-market imports or counterfeit products.

The consultation takes under three minutes and covers your medical history, current medications, and weight loss goals. If Mounjaro isn't suitable based on your assessment, our prescribers will recommend alternative treatments from our weight loss range, ensuring you receive the most appropriate medication for your individual circumstances.

Understanding Mounjaro: The Dual-Action Weight Loss Treatment

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates two complementary hormone systems that regulate appetite, food intake, and glucose metabolism, producing significantly greater weight reduction in clinical trials.

In the landmark SURMOUNT-1 trial, participants taking the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks — the highest efficacy demonstrated by any obesity medication in clinical studies to date [1]. The dual mechanism works by mimicking GLP-1 (glucagon-like peptide-1) to reduce appetite and slow gastric emptying, whilst simultaneously activating GIP (glucose-dependent insulinotropic polypeptide) receptors to enhance insulin secretion and improve metabolic function.

Mounjaro is administered as a once-weekly subcutaneous injection using the KwikPen device, which features a hidden needle and simple push-button operation. The treatment follows a gradual dose escalation schedule starting at 2.5mg, increasing every four weeks to minimise gastrointestinal side effects whilst allowing your body to adjust to the medication [2].

Who Can Use Mounjaro in the UK?

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Your UK prescriber will calculate your BMI during the online consultation and assess whether tirzepatide is clinically appropriate based on your medical history, current medications, and any contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Mounjaro vs Wegovy: Comparing UK Weight Loss Injections

Both Mounjaro and Wegovy are MHRA-licensed injectable treatments for weight management, but they differ significantly in their mechanism of action and clinical efficacy. Wegovy contains semaglutide, a GLP-1 receptor agonist that works through a single pathway, whilst Mounjaro's tirzepatide activates both GLP-1 and GIP receptors for dual-action metabolic effects.

Head-to-head trial data from SURPASS-2 demonstrated that tirzepatide produced superior weight loss compared to semaglutide at equivalent timepoints, with the 15mg tirzepatide dose achieving approximately 6% greater body weight reduction than 1mg semaglutide over 40 weeks [3]. However, individual response varies considerably, and some patients may achieve excellent results with semaglutide-based treatments whilst experiencing tolerability issues with tirzepatide.

Wegovy is available at Cured Pharmacy with competitive UK pricing, and our prescribers will discuss both options during your consultation to determine which treatment aligns best with your medical profile, lifestyle preferences, and budget. Some patients prefer starting with semaglutide due to its longer track record in clinical practice, whilst others opt for tirzepatide's enhanced efficacy profile despite the higher cost.

Side Effect Profiles: What to Expect

Both medications share similar gastrointestinal side effects including nausea, diarrhoea, constipation, and reduced appetite, which typically improve after the first few weeks as your body adjusts [1][3]. The gradual dose escalation protocol minimises these effects, though approximately 5-10% of patients discontinue treatment due to persistent tolerability issues. Rare but serious side effects include pancreatitis, gallbladder disease, and thyroid tumours (observed in rodent studies but not confirmed in humans). Your prescriber will monitor for warning signs during follow-up consultations.

Complete Weight Loss Treatment Options at Cured Pharmacy

Beyond Mounjaro, we offer a comprehensive range of MHRA-licensed weight loss treatments to suit different clinical needs and budgets. Our GLP-1 receptor agonist portfolio includes Wegovy (semaglutide) injections and the newly available Wegovy oral tablets, which provide the same active ingredient in a convenient daily pill format for patients who prefer to avoid injections.

For patients seeking more affordable options, we dispense Saxenda (liraglutide), a daily injection that has been available in the UK since 2017 with an established safety profile across millions of patient-years of use. Saxenda works through the same GLP-1 pathway as Wegovy but requires daily rather than weekly administration.

We also stock lipase inhibitor treatments including prescription-strength Orlistat 120mg, branded Xenical, and lower-dose over-the-counter options such as Alli 60mg and Orlos. These work by blocking approximately 30% of dietary fat absorption rather than suppressing appetite, making them suitable for patients who cannot tolerate GLP-1 medications or prefer a non-hormonal approach to weight management [4].

How to Order Mounjaro Online from Cured Pharmacy

Ordering Mounjaro through our online pharmacy takes less than five minutes from start to finish. Begin by clicking 'Start Assessment' on the Mounjaro product page, which opens our secure clinical questionnaire covering your medical history, current medications, allergies, and weight loss goals. The questionnaire is reviewed by one of our UK-registered prescribers, typically within 24 hours on weekdays.

If your prescriber approves Mounjaro based on your assessment, you'll receive an email confirmation with your prescription details and tracking information once your order is dispatched. All medications are sent in plain, unmarked packaging with no external indication of contents, ensuring complete discretion. We use Royal Mail Tracked 24 or DPD next-day delivery depending on your location and urgency requirements.

Your prescription includes detailed administration instructions, information on managing potential side effects, and guidance on when to escalate your dose. Our pharmacy team remains available on (+44) 116 4646009 during business hours if you have questions about injection technique, storage requirements, or any concerns during your treatment journey. Follow-up consultations are required every 12 weeks to monitor your progress and adjust your prescription as needed.

What Happens If Mounjaro Isn't Suitable?

If our prescriber determines that Mounjaro isn't clinically appropriate based on your medical assessment, they'll provide clear reasoning and recommend alternative treatments that may be more suitable. This might include switching to semaglutide-based options, trying a lipase inhibitor approach, or suggesting lifestyle modifications before starting pharmacological treatment. You won't be charged for consultations where no prescription is issued, reflecting our commitment to ethical prescribing practices rather than sales-driven medicine.

Maximising Your Results: Lifestyle Factors That Matter

Whilst Mounjaro produces substantial weight loss through its pharmacological effects, clinical trial data consistently shows that patients who combine medication with structured lifestyle changes achieve superior long-term outcomes [1]. The SURMOUNT trials incorporated dietary counselling and increased physical activity alongside tirzepatide, contributing to the impressive 22.5% average weight reduction observed in study participants.

NICE guidance on obesity management recommends a reduced-calorie diet (typically 500-600 kcal daily deficit), at least 150 minutes of moderate-intensity aerobic activity per week, and behavioural strategies to address emotional eating patterns and food environment triggers [5]. Mounjaro's appetite-suppressing effects make it significantly easier to adhere to calorie targets, as the medication reduces hunger signals and increases satiety after smaller portions.

Many patients find that Mounjaro changes their relationship with food, reducing cravings for high-calorie processed foods and making it easier to choose nutrient-dense options. However, it's important to ensure adequate protein intake (at least 1.2g per kilogram of body weight) to preserve lean muscle mass during weight loss, as rapid fat loss can be accompanied by muscle wasting if dietary protein is insufficient [6]. Our prescribers can provide personalised nutrition guidance during your consultation and follow-up appointments.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://products.mhra.gov.uk/ [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. Pasiakos, S. M., Cao, J. J., Margolis, L. M., et al. (2013). Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB Journal, 27(9), 3837–3847. https://doi.org/10.1096/fj.13-230227 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle factors. Mounjaro is a prescription-only medicine and may not be suitable for everyone.